Skip to main menu Skip to main content Skip to footer

Jeff Rihn, EyeSouth Partners Director of Clinical Research

Practice Administrator at Scott & Christie Eyecare Associates

Jeff Rihn is a highly experienced professional with a diverse portfolio of roles within EyeSouth Partners (ESP) and Scott & Christie EyeCare Associates (SCEA). At ESP, he serves as the Director of Clinical Research and the Regional Director of Operations for Pennsylvania. Simultaneously, at SCEA, Jeff holds the positions of Practice Administrator, Regulatory Administrator in the Research Department, and Governing Body Member for the Cranberry Surgery Center

With an impressive 30 years in ophthalmology and 25 years in clinical research, Jeff brings a wealth of knowledge to his roles. Having actively participated in 164 clinical trials with 3500 study subjects, he has established himself as a formidable force in the clinical research field for ophthalmology. 

Jeff’s expertise extends to strategic planning, process improvement, clinical research studies, mentoring future leaders, and driving growth initiatives within ophthalmology. His primary goal as the Clinical Research Director at ESP is to establish a network of high-performing investigators and sites, positioning ESP as a leading national ophthalmology clinical research program.  

As the Director of Clinical Research, Jeff understands the critical role of data integrity for clinical studies in the drug approval process, emphasizing a culture of issue identification and correction. 

Jeff graduated with a bachelor’s degree from Indiana University of Pennsylvania, majoring in Accounting and Finance with a minor in Economics. He has also been a Certified Public Accountant in Pennsylvania since 1990.Outside his professional pursuits, Jeff is a dedicated single dad to two adopted boys, enjoys painting, renovating houses, and antique hunting. Jeff extends his commitment to the community by serving on the board for Mission -Vision, providing mobile eye care to the underprivileged in Pittsburgh.